Jose A. Wippold , Monica Chu , Rebecca Renberg , Yuwen Li , Bryn Adams , Arum Han
{"title":"XPORT ENTRAP: A droplet microfluidic platform for enhanced DNA transfer between microbial species","authors":"Jose A. Wippold , Monica Chu , Rebecca Renberg , Yuwen Li , Bryn Adams , Arum Han","doi":"10.1016/j.nbt.2024.02.003","DOIUrl":null,"url":null,"abstract":"<div><p>A significant hurdle for the widespread implementation and use of synthetic biology is the challenge of highly efficient introduction of DNA into microorganisms. This is especially a barrier for the utilization of non-model organisms and/or novel chassis species for a variety of applications, ranging from molecular biology to biotechnology and biomanufacturing applications. Common approaches to episomal and chromosomal gene editing, which employ techniques such as chemical competence and electroporation, are typically only amenable to a small subset of microbial species while leaving the vast majority of microorganisms in nature genetically inaccessible. To address this challenge, we have employed the previously described B. subtilis broad-host conjugation strain, XPORT, which was modularly designed for loading DNA cargo and conjugating such DNA into recalcitrant microbes. In this current work, we have leveraged and adapted the XPORT strain for use in a droplet microfluidic platform to enable increased efficiency of conjugation-based DNA transfer. The system named DNA ENTRAP (DNA ENhanced TRAnsfer Platform) utilizes cell-encapsulated water-in-oil emulsion droplets as pico-liter-volume bioreactors that allows controlled contacts between the donor and receiver cells within the emulsion bioreactor. This allowed enhanced XPORT-mediated genetic transfer over the current benchtop XPORT process, demonstrated using two different Bacillus subtilis strains (donor and receiver), as well as increased throughput (e.g., number of successfully conjugated cells) due to the automated assay steps inherent to microfluidic lab-on-a-chip systems. DNA ENTRAP paves the way for a streamlined automation of culturing and XPORT-mediated genetic transfer processes as well as future high-throughput cell engineering and screening applications.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":"81 ","pages":"Pages 10-19"},"PeriodicalIF":4.5000,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1871678424000050/pdfft?md5=867a11eebe725573f887c953217efece&pid=1-s2.0-S1871678424000050-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871678424000050","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
A significant hurdle for the widespread implementation and use of synthetic biology is the challenge of highly efficient introduction of DNA into microorganisms. This is especially a barrier for the utilization of non-model organisms and/or novel chassis species for a variety of applications, ranging from molecular biology to biotechnology and biomanufacturing applications. Common approaches to episomal and chromosomal gene editing, which employ techniques such as chemical competence and electroporation, are typically only amenable to a small subset of microbial species while leaving the vast majority of microorganisms in nature genetically inaccessible. To address this challenge, we have employed the previously described B. subtilis broad-host conjugation strain, XPORT, which was modularly designed for loading DNA cargo and conjugating such DNA into recalcitrant microbes. In this current work, we have leveraged and adapted the XPORT strain for use in a droplet microfluidic platform to enable increased efficiency of conjugation-based DNA transfer. The system named DNA ENTRAP (DNA ENhanced TRAnsfer Platform) utilizes cell-encapsulated water-in-oil emulsion droplets as pico-liter-volume bioreactors that allows controlled contacts between the donor and receiver cells within the emulsion bioreactor. This allowed enhanced XPORT-mediated genetic transfer over the current benchtop XPORT process, demonstrated using two different Bacillus subtilis strains (donor and receiver), as well as increased throughput (e.g., number of successfully conjugated cells) due to the automated assay steps inherent to microfluidic lab-on-a-chip systems. DNA ENTRAP paves the way for a streamlined automation of culturing and XPORT-mediated genetic transfer processes as well as future high-throughput cell engineering and screening applications.
合成生物学的广泛实施和应用面临的一个重大障碍是如何高效地将 DNA 导入微生物。这对于利用非模式生物和/或新型底盘物种进行各种应用(从分子生物学到生物技术和生物制造应用)来说,尤其是一个障碍。利用化学能力和电穿孔等技术进行外显子和染色体基因编辑的常见方法通常只适用于一小部分微生物物种,而自然界中绝大多数微生物的基因都无法编辑。为了应对这一挑战,我们采用了之前描述过的枯草杆菌广宿主共轭菌株 XPORT,该菌株采用模块化设计,可装载 DNA 货物并将这种 DNA 共轭到难缠的微生物中。在目前的工作中,我们利用并改造了 XPORT 菌株,将其用于液滴微流控平台,以提高基于共轭的 DNA 转移效率。这个名为 DNA ENTRAP(DNA ENhanced TRAnsfer Platform)的系统利用细胞封装的油包水乳液液滴作为皮升容量的生物反应器,从而控制乳液生物反应器中供体和受体细胞之间的接触。通过使用两种不同的枯草杆菌菌株(供体和受体)演示,这使得 XPORT 介导的基因转移比目前的台式 XPORT 过程更强,而且由于微流控芯片实验室系统固有的自动测试步骤,吞吐量(如成功连接的细胞数量)也得到了提高。DNA ENTRAP 为培养和 XPORT 介导的基因转移过程的简化自动化以及未来的高通量细胞工程和筛选应用铺平了道路。
期刊介绍:
New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international.
The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.